• OPEN AN ACCOUNT
Indian Indices
Sensex
78,954.76 373.76
( 0.48%)
Global Indices
Nasdaq
54,370.92 264.04
(0.49%)
Dow Jones
7,742.03 -15.49
(-0.20%)
Hang Seng
65,663.80 -636.64
(-0.96%)
Nikkei 225
10,873.25 -15.05
(-0.14%)
Forex
USD-INR
95.23 -0.06
(-0.07%)
EUR-INR
109.68 -0.11
(-0.10%)
GBP-INR
127.98 -0.19
(-0.15%)
JPY-INR
0.60 0.00
(-0.60%)

EQUITY - MARKET SCREENER

Concord Biotech Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
543960
INE338H01029
193.0629905
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
CONCORDBIO
50.86
14462.67
EPS(TTM)
Face Value()
Div & Yield %
27.18
1
0.55
 

As on: Aug 06, 2026 12:00 AM

Last Price() Net Change (%) Volume (Nos) P / E
1,375.00 -7.45 2878 50.86
Stock Price Details
Open Price() 1,396.25
Best Buy () 0
Best Sell () 0
Buy Quantity (Nos) 0
Sell Quantity (Nos) 0
Today's High () 1,411.15
Today's Low () 1,370.00
52-Week High () 1803.6
152-Week Low () 987.05
CHART
  • |
  • |
  • |
  • |
Market Statistics
Div & Yield % 0.55
Eps 27.18
Book Value 193.0629905
Market Cap (.Cr) 14,462.67
Face Value 1
Market Lot 1
AGM Date Jul
Book Closure Date
ISIN No. INE338H01029


News
Concord Biotech consolidated net profit rises 32.84% in the June 2026 quarter
Concord Biotech to discuss results
Concord Biotech schedules AGM
Concord Biotech fixes record date for final dividend
Concord Biotech’s formulation facility clears regulatory inspections by Kenya's PPB & Uganda's NDA
Concord Biotech's Unit II formulations unit successfully clears PPB and NDA inspection
Concord Biotech's Limbasi unit clears Brazilian health regulatory inspection
Concord Biotech completes ANVISA inspection at Limbasi API facility
Concord Biotech rallies after USFDA approval for Tofacitinib tablets
Concord Biotech receives USFDA approval for Tofacitinib Tablets
More
Corporate Details
Incoporation Year   : 1984
Chairman : SUDHIR JAIRAM VAID
Bussiness Group : Indian Private
Registered Office
Concord Biotech Ltd
1482-86 Trasad Road,
Dholka,
Ahmedabad,
Gujarat-382225
Cement House,
121 Maharshi Karve Road,
Mumbai,
Maharashtra-400020
Phone:91-079-68138700
Fax:N.A.
Fax:91-22-66317458
E-Mail : complianceofficer@concordbiotech.com
URL : http://www.concordbiotech.com


Exchange Information
Bombay Stock Exchange National Stock Exchange Other Listed Exchanges
  • BSE 500
  • BSE HC
  • BSE SmallCap
  • CNX 500
  • BSE
  • Kolkata
  • Chennai
  • Ahmedabad
  • Delhi
  • Kochi